Home » Topics » Disease categories and therapies » Immune

Immune
RSS

LXR issued two U.S. patents for naturally occurring death receptor

Oct. 22, 1997

Novartis granted option for TP-10 in xeno/allotransplants; preliminary results in lung transplant

Oct. 21, 1997

Australian government awards Cortecs grant for otitis media research

Oct. 20, 1997

Advisory panel to the FDA unanimously recommends PDL's Zenapax

Oct. 20, 1997

VZV vaccines using gene product expressed during latency

Oct. 17, 1997

BioTransplant and Novartis expand xenotransplantation collaboration

Oct. 15, 1997

Magnetic protein conjugates from Behringwerke

Oct. 15, 1997

LXR files IDE with FDA for heart preservation solution

Oct. 14, 1997

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

Aviron updates vaccine clinical program

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026